Factors | Â | No. | Rate |
---|---|---|---|
Age | Â | Â | Â |
 | Range | 56-95 years old |  |
 | Median | 73 years old |  |
Sex | Â | Â | Â |
 | Male | 48 | 72% |
 | Female | 19 | 28% |
K-PS | Â | Â | Â |
 | 90-100% | 39 | 58% |
 | 80-90% | 20 | 30% |
 | 70% | 2 | 3% |
 | Unknown | 6 | 9% |
Smoking history | Â | Â | Â |
 | With | 29 | 43% |
 | Without | 17 | 25% |
 | Unknown | 21 | 31% |
T stage | Â | Â | Â |
 | T1a | 28 | 42% |
 | T1b | 14 | 21% |
 | T2 | 6 | 9% |
 | T3 | 3 | 4% |
 | Metastatic | 16 | 24% |
Pathological confirmation | Â | Â | Â |
 | Without | 26 | 39% |
 | With | 41 | 61% |
Maximum diameter of primary tumor | Â | Â | Â |
 | Range | 7-51 mm | |
 | Median | 20 mm | |
Tumor location | Â | Â | Â |
 | Left upper | 18 | 27% |
 | Left lower | 10 | 15% |
 | Right upper | 17 | 25% |
 | Right middle | 9 | 13% |
 | Right lower | 13 | 19% |
Combined chemotherapy | Â | Â | Â |
 | Both before and after SBRT | 2 | 3% |
 | Before SBRT | 5 | 7% |
 | After SBRT | 3 | 4% |
 | None | 57 | 85% |